PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10225882-2	1999	Infection with both E. chaffeensis and E. sennetsu, but not HGE agent, in the acute monocytic leukemia cell line THP-1 almost completely inhibited by treatment with deferoxamine, a cell-permeable iron chelator.	Deferoxamine	165-177	GLI family zinc finger 2	Homo sapiens	113-118	
16632111-2	2006	Here we report that iron chelator deferoxamine (DFO) induces differentiation of monocytic THP-1 cells into functional macrophages.	Deferoxamine	48-51	GLI family zinc finger 2	Homo sapiens	90-95	
16632111-4	2006	Blockade of ERK signaling by the MEK1/2 inhibitor PD098059 abolished DFO-induced class A scavenger receptor (SR-A) expression and phagocytic activity, indicating that ERK cascades mediate the induction of THP-1 differentiation.	Deferoxamine	69-72	GLI family zinc finger 2	Homo sapiens	205-210	
16632111-8	2006	Collectively, these results indicate that oxidative stress by DFO and the resulting activation of ERK cascade play dominant roles in the process of THP-1 differentiation, while p38 acts as a negative signal transmitter.	Deferoxamine	62-65	GLI family zinc finger 2	Homo sapiens	148-153	
9338146-8	1997	Addition of iron chelator deferoxamine (50 microM, i.e., about half-maximal growth-inhibitory dose) resulted in significantly increased activity of IRP also in HeLa and THP-1 cells.	Deferoxamine	26-38	GLI family zinc finger 2	Homo sapiens	169-174